Strongest Antibiotic Approved
From Associated Press
Today, the FDA approved Synercid to treat vancomycin-resistant enterococcal infections, a life-threatening infection that typically strikes hospital patients.
One recent study estimated as many as 52 percent of enterococcal infections are now vancomycin-resistant, making them difficult if not impossible to treat.
The FDA also approved Synercid to treat certain complicated skin infections caused by Staphylococcus aureus bacteria, commonly known as staph infections.
But it is not a miracle drug. Synercid doesn’t work as well as existing antibiotics for some infections, scientists have stressed and because bacteria evolve rapidly, Synercid resistance eventually will appear, too.
planetc1.com-news @ 16:06 | Article ID: 937948004